发明名称 |
NEW DROSPIRENONE/17BETA-ESTRADIOL REGIMEN, PHARMACEUTICAL COMBINATION PRODUCT AND KIT FOR PERFORMING THIS REGIMEN. |
摘要 |
<p>The present invention relates to a pharmaceutical combination product with at least 21 daily consecutive dosage units containing from 2.0 mg to 3.0 mg of drospirenone and 1.0 to 2.0 mg of 17β-estradiol in each daily dosage unit followed by intermittent daily dosage units containing the same or smaller amount of drospirenone (i.e. 0.5 mg to 3.0 mg) as the consecutive daily dosage units wherein each intermittent daily dosage unit is preceded by at least one day without administration of drospirenone. These pharmaceutical combination products can be used for female oral contraception, guarantee a withdrawal bleeding each 4 weeks and allow for the full maintenance of the drospirenone related benefits.</p> |
申请公布号 |
MX2009010763(A) |
申请公布日期 |
2009.10.28 |
申请号 |
MX20090010763 |
申请日期 |
2008.04.07 |
申请人 |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
发明人 |
VLADIMIR HANES;HARTMUT BLODE;ROLF SCHUERMANN;BERND DUESTERBERG;JOACHIM MARR |
分类号 |
A61K31/585;A61K31/565 |
主分类号 |
A61K31/585 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|